Annual CFO
-$31.98 M
-$8.86 M-38.30%
December 1, 2023
Summary
- As of February 7, 2025, MBX annual cash flow from operations is -$31.98 million, with the most recent change of -$8.86 million (-38.30%) on December 1, 2023.
- During the last 3 years, MBX annual CFO has fallen by -$8.86 million (-38.30%).
- MBX annual CFO is now -38.30% below its all-time high of -$23.12 million, reached on December 1, 2022.
Performance
MBX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$14.66 M
NaN%
September 30, 2024
Summary
- As of February 7, 2025, MBX quarterly cash flow from operations is -$14.66 million
- Over the past year, MBX quarterly CFO has dropped by -$6.94 million (-89.80%).
- MBX quarterly CFO is now -89.80% below its all-time high of -$7.73 million, reached on September 30, 2023.
Performance
MBX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$14.66 M
NaN%
September 30, 2024
Summary
- As of February 7, 2025, MBX TTM cash flow from operations is -$14.66 million
- Over the past year, MBX TTM CFO has dropped by -$6.94 million (-89.80%).
- MBX TTM CFO is now -89.80% below its all-time high of -$7.73 million, reached on September 30, 2023.
Performance
MBX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MBX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.3% | -89.8% | -89.8% |
| 3 y3 years | -38.3% | -89.8% | -89.8% |
| 5 y5 years | -38.3% | -89.8% | -89.8% |
MBX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.3% | at low | -89.8% | at low | -89.8% | at low |
| 5 y | 5-year | -38.3% | at low | -89.8% | at low | -89.8% | at low |
| alltime | all time | -38.3% | at low | -89.8% | at low | -89.8% | at low |
MBX Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.66 M(+89.8%) | -$14.66 M(+89.8%) |
| Dec 2023 | -$31.98 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$7.73 M | -$7.73 M |
| Dec 2022 | -$23.12 M | - | - |
FAQ
- What is MBX Biosciences annual cash flow from operations?
- What is the all time high annual CFO for MBX Biosciences?
- What is MBX Biosciences annual CFO year-on-year change?
- What is MBX Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for MBX Biosciences?
- What is MBX Biosciences quarterly CFO year-on-year change?
- What is MBX Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for MBX Biosciences?
- What is MBX Biosciences TTM CFO year-on-year change?
What is MBX Biosciences annual cash flow from operations?
The current annual CFO of MBX is -$31.98 M
What is the all time high annual CFO for MBX Biosciences?
MBX Biosciences all-time high annual cash flow from operations is -$23.12 M
What is MBX Biosciences annual CFO year-on-year change?
Over the past year, MBX annual cash flow from operations has changed by -$8.86 M (-38.30%)
What is MBX Biosciences quarterly cash flow from operations?
The current quarterly CFO of MBX is -$14.66 M
What is the all time high quarterly CFO for MBX Biosciences?
MBX Biosciences all-time high quarterly cash flow from operations is -$7.73 M
What is MBX Biosciences quarterly CFO year-on-year change?
Over the past year, MBX quarterly cash flow from operations has changed by -$6.94 M (-89.80%)
What is MBX Biosciences TTM cash flow from operations?
The current TTM CFO of MBX is -$14.66 M
What is the all time high TTM CFO for MBX Biosciences?
MBX Biosciences all-time high TTM cash flow from operations is -$7.73 M
What is MBX Biosciences TTM CFO year-on-year change?
Over the past year, MBX TTM cash flow from operations has changed by -$6.94 M (-89.80%)